Brief: Marksans Pharma March-Quarter Consol Profit Rises
31/05/2021 08:07
May 31 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARKSANS PHARMA LTD - MARCH-QUARTER CONSOL PROFIT 795 MILLION RUPEES VERSUS 427.4 MILLION
RUPEES
YEAR AGO
* MARKSANS PHARMA LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 3.30 BILLION RUPEES
VERSUS 3.35
BILLION RUPEES YEAR AGO
Source text - https://bit.ly/3fUXGat
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg